• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有体细胞激活突变的纤维脂肪血管异常(FAVA)病例报告

Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic Mutation.

作者信息

Driskill Jordan H, Hwang Helena, Callan Alexandra K, Oliver Dwight

机构信息

Medical Scientist Training Program, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Case Rep Genet. 2022 Aug 2;2022:9016497. doi: 10.1155/2022/9016497. eCollection 2022.

DOI:10.1155/2022/9016497
PMID:35967928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9363927/
Abstract

Fibro-adipose vascular anomaly (FAVA) is a recently described complex and painful benign lesion found in young adults and the pediatric population composed of intramuscular vascular, fibrous, and adipose tissues. A previous report has identified the presence of somatic mosaic mutations in the gene for the catalytic subunit of phosphatidylinositol 3-kinase () in cases of FAVA. Herein, we present a case of FAVA found in a 23-year-old male patient who presented with chronic wrist pain associated with a mass, and we identified an associated somatic activating mutation (H1047R) in . We briefly review the relevant literature surrounding the identification and histology of FAVA, the known mutational spectrum, downstream signaling pathways, and relevant treatment modalities. Our case highlights the association between FAVA and somatic mosaic activating mutations.

摘要

纤维脂肪血管异常(FAVA)是一种最近才被描述的复杂且疼痛的良性病变,见于年轻人和儿童群体,由肌内血管、纤维和脂肪组织构成。先前的一份报告已确定在FAVA病例中,磷脂酰肌醇3激酶(PI3K)催化亚基基因存在体细胞镶嵌突变。在此,我们报告一例在一名23岁男性患者中发现的FAVA,该患者表现为与肿块相关的慢性腕部疼痛,并且我们在PI3K中鉴定出一个相关的体细胞激活突变(H1047R)。我们简要回顾了围绕FAVA的识别、组织学、已知突变谱、下游信号通路及相关治疗方式的相关文献。我们的病例突出了FAVA与体细胞镶嵌激活突变之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/b6afb67a925d/CRIG2022-9016497.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/e79a8ee0986b/CRIG2022-9016497.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/5f5a0693e7dc/CRIG2022-9016497.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/b6afb67a925d/CRIG2022-9016497.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/e79a8ee0986b/CRIG2022-9016497.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/5f5a0693e7dc/CRIG2022-9016497.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0871/9363927/b6afb67a925d/CRIG2022-9016497.003.jpg

相似文献

1
Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic Mutation.伴有体细胞激活突变的纤维脂肪血管异常(FAVA)病例报告
Case Rep Genet. 2022 Aug 2;2022:9016497. doi: 10.1155/2022/9016497. eCollection 2022.
2
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.纤维脂肪血管异常(FAVA):三例病例报告,重点介绍哺乳动物雷帕霉素靶蛋白(mTOR)通路。
Diagn Pathol. 2020 Jul 25;15(1):98. doi: 10.1186/s13000-020-01004-z.
3
PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA).PIK3CA 突变与 mTOR 通路表达相关,但与纤维脂肪性血管异常(FAVA)的临床和病理特征无关。
Diagn Pathol. 2022 Jan 30;17(1):19. doi: 10.1186/s13000-022-01199-3.
4
Fibro-Adipose Vascular Anomaly (FAVA): Not Another Vascular Anagram.纤维脂肪性血管异常(FAVA):并非另一个血管变位词。
Int J Surg Pathol. 2023 Jul 17:10668969231188419. doi: 10.1177/10668969231188419.
5
Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder.下肢纤维脂肪血管异常(FAVA):一种新界定疾病的新病例。
Ann Vasc Dis. 2014;7(3):316-9. doi: 10.3400/avd.cr.14-00049. Epub 2014 Jul 30.
6
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.淋巴管及其他血管畸形/过度生长疾病由PIK3CA基因的体细胞突变引起。
J Pediatr. 2015 Apr;166(4):1048-54.e1-5. doi: 10.1016/j.jpeds.2014.12.069. Epub 2015 Feb 11.
7
Fibro-adipose vascular anomaly (FAVA) - diagnosis, staging and management.纤维脂肪性血管异常(FAVA) - 诊断、分期和管理。
Orphanet J Rare Dis. 2023 Nov 7;18(1):347. doi: 10.1186/s13023-023-02961-6.
8
Fibro-Adipose Vascular Anomaly: A Case Report and Literature Review.纤维脂肪血管异常:一例报告及文献综述
Cureus. 2022 Oct 27;14(10):e30757. doi: 10.7759/cureus.30757. eCollection 2022 Oct.
9
Bilateral Nephroblastic Tumors and a Complex Renal Vascular Anomaly in a Patient With a Mosaic RASopathy: Novel Histopathologic Features and Molecular Insights.患者存在 RAS 相关镶嵌综合征,表现为双侧肾母细胞瘤样肿瘤和复杂肾脏血管畸形:新的组织病理学特征和分子见解。
Pediatr Dev Pathol. 2021 May-Jun;24(3):235-240. doi: 10.1177/1093526620986502. Epub 2021 Feb 4.
10
Fibroadipose vascular anomaly: a clinicopathological study of 75 cases.纤维脂肪性血管异常:75例临床病理研究
Histopathology. 2023 Aug;83(2):286-297. doi: 10.1111/his.14923. Epub 2023 Apr 26.

引用本文的文献

1
Fibroadipose Vascular Anomaly [FAVA] - A Distinct Entity and Not Just a Malformation!纤维脂肪血管异常[FAVA]——一种独特的实体,而非仅仅是一种畸形!
J Orthop Case Rep. 2024 Dec;14(12):98-101. doi: 10.13107/jocr.2024.v14.i12.5034.
2
FAVA Syndrome with Unique Synovial Localisation Mimicking Diffuse Pigmented Villonodular Synovitis.伴有独特滑膜定位的FAVA综合征,酷似弥漫性色素沉着绒毛结节性滑膜炎。
Balkan Med J. 2025 Jan 2;42(1):83-85. doi: 10.4274/balkanmedj.galenos.2024.2024-7-12. Epub 2024 Nov 26.
3
A painful mass infiltrating the quadriceps compartment of a young female.

本文引用的文献

1
PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA).PIK3CA 突变与 mTOR 通路表达相关,但与纤维脂肪性血管异常(FAVA)的临床和病理特征无关。
Diagn Pathol. 2022 Jan 30;17(1):19. doi: 10.1186/s13000-022-01199-3.
2
Somatic Mutations in Sporadic Cerebral Cavernous Malformations.散发性脑动静脉畸形中的体细胞突变。
N Engl J Med. 2021 Sep 9;385(11):996-1004. doi: 10.1056/NEJMoa2100440.
3
A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations.
一名年轻女性的股四头肌间隙出现一个有压痛的肿块。
Skeletal Radiol. 2024 Nov;53(11):2547-2550. doi: 10.1007/s00256-024-04617-3. Epub 2024 Feb 20.
4
Progress about the fibro-adipose vascular anomaly: A review.纤维脂肪血管异常的研究进展:综述。
Medicine (Baltimore). 2024 Feb 16;103(7):e37225. doi: 10.1097/MD.0000000000037225.
PIK3CA 相关血管病变疾病发病机制的综述
Orphanet J Rare Dis. 2021 Jul 8;16(1):306. doi: 10.1186/s13023-021-01929-8.
4
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.纤维脂肪血管异常(FAVA):三例病例报告,重点介绍哺乳动物雷帕霉素靶蛋白(mTOR)通路。
Diagn Pathol. 2020 Jul 25;15(1):98. doi: 10.1186/s13000-020-01004-z.
5
Fibroadipose Vascular Anomaly in the Upper Extremity: A Distinct Entity With Characteristic Clinical, Radiological, and Histopathological Findings.上肢纤维脂肪血管异常:一种具有独特临床、放射学和组织病理学特征的实体。
J Hand Surg Am. 2020 Jan;45(1):68.e1-68.e13. doi: 10.1016/j.jhsa.2019.05.008. Epub 2019 Jul 3.
6
Somatic activating mutations in cause generalized lymphatic anomaly.在 中发现的体激活突变导致全身淋巴异常。
J Exp Med. 2019 Feb 4;216(2):407-418. doi: 10.1084/jem.20181353. Epub 2018 Dec 27.
7
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders.肿瘤相关 PIK3CA 突变与过度生长疾病。
Trends Mol Med. 2018 Oct;24(10):856-870. doi: 10.1016/j.molmed.2018.08.003. Epub 2018 Sep 6.
8
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.PIK3CA 相关过度生长综合征患者的靶向治疗。
Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13.
9
Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients.用西罗莫司治疗纤维脂肪血管异常:两名患者取得成功结果。
Pediatr Dermatol. 2017 Nov;34(6):e317-e320. doi: 10.1111/pde.13260.
10
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.磷脂酰肌醇-3激酶催化亚基α(PIK3CA)的体细胞激活突变可导致小鼠和人类出现散发性静脉畸形。
Sci Transl Med. 2016 Mar 30;8(332):332ra43. doi: 10.1126/scitranslmed.aad9982.